Clinical Trials Browser

Phase 1/2 × Withdrawn × eribulin × Clear all

NCT04826016 2023-03-20

POLTER

Phase 1/2 Withdrawn

Advanced Breast Cancer

NCT02396433 2015-08-25

Combination of Carboplatin, Eribulin Mesylate, and E7449 in BRCA-Related Cancers

Phase 1/2 Withdrawn

Breast Neoplasms